Holen Sie sich die Stockscreener-App
492.60
0.64%
3.11
Handel nachbörslich:
492.60
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$489.49
Offen:
$490
24-Stunden-Volumen:
1.44M
Relative Volume:
0.59
Marktkapitalisierung:
$186.01B
Einnahmen:
$43.21B
Nettoeinkommen (Verlust:
$6.58B
KGV:
28.49
EPS:
17.29
Netto-Cashflow:
$6.17B
1W Leistung:
-0.02%
1M Leistung:
+5.61%
6M Leistung:
-6.03%
1J Leistung:
-18.83%
1-Tages-Spanne:
$489.12
$502.00
1-Wochen-Bereich:
$471.61
$502.00
52-Wochen-Spanne:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
492.60 | 184.84B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.21 | 142.52B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
642.99 | 51.24B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
128.75 | 36.42B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.68 | 31.29B | 15.70B | 1.24B | 2.01B | 6.91 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Earnings visualization tools for Thermo Fisher Scientific Inc.Weekly Market Outlook & Fast Exit and Entry Trade Guides - Newser
Historical volatility pattern of Thermo Fisher Scientific Inc. visualized2025 Market Overview & Low Drawdown Momentum Ideas - Newser
Transcript : Thermo Fisher Scientific Inc.Special Call - MarketScreener
Oncology Molecular Diagnostics Market Size Drives USD 9.76 Billion by 2034 - GlobeNewswire Inc.
Does Thermo Fisher Scientific Inc. show high probability of reboundJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - Newser
Published on: 2025-09-04 16:51:09 - khodrobank.com
Shigella Test Kit Market to Witness Remarkable Growth with Thermo Fisher Scientific Inc., Meridian Bioscience Inc - openPR.com
Published on: 2025-09-04 04:06:21 - khodrobank.com
Stock Analysis | Thermo Fisher OutlookMixed Signals Amid Strong Fundamentals - AInvest
Trend analysis for Thermo Fisher Scientific Inc. this weekJobs Report & Smart Swing Trading Alerts - Newser
Thermo Fisher's $4B Solventum Acquisition Triggers Mixed Market Reaction as Stock Slips 0.61% to $481.50 Volume Ranks 158th on $590M Turnover - AInvest
What’s the analyst consensus on Thermo Fisher Scientific Inc.Inflation Watch & High Conviction Buy Zone Alerts - khodrobank.com
Thermo Fisher completes purchase of Sanofi site in New Jersey - WFMZ.com
Is Thermo Fisher Scientific Inc.’s growth already priced inVolume Spike & Technical Buy Zone Confirmations - khodrobank.com
Here’s Why Thermo Fisher Scientific (TMO) Traded Lower in Q2 - Yahoo Finance
Biobanking Services Market Expansion Led by Key Players: Thermo - openPR.com
RBC Trims Price Target on Thermo Fisher Scientific to $561 From $572, Keeps Outperform Rating - MarketScreener
Can trapped investors hope for a rebound in Thermo Fisher Scientific Inc.2025 Top Gainers & Reliable Price Breakout Alerts - Newser
Thermo Fisher acquires Solventum’s filtration unit for $4B - Modern Healthcare
Flow Cytometry Market Insights, Growth Outlook and - GlobeNewswire
Should you hold or exit Thermo Fisher Scientific Inc. now2025 Stock Rankings & Long-Term Safe Investment Plans - Newser
Thermo Fisher Scientific Inc. stock daily chart insightsPortfolio Performance Summary & Short-Term Swing Trade Alerts - Newser
Thermo Fisher Scientific Inc. stock retracement – recovery analysisQuarterly Risk Review & Safe Capital Growth Trade Ideas - Newser
What data driven models say about Thermo Fisher Scientific Inc.’s futureJuly 2025 Review & Real-Time Chart Breakout Alerts - Newser
Thermo Fisher Scientific concludes acquisition of Sanofi New Jersey site - Medical Dialogues
How liquid is Thermo Fisher Scientific Inc. stockJuly 2025 Reactions & Consistent Growth Equity Picks - khodrobank.com
Thermo Fisher Plummets 1.05% on $630M Trading Volume Ranked 165th as Acquisition Expands U.S. Pharma Manufacturing Footprint - AInvest
Why Thermo Fisher Scientific Stock Tumbled Today - The Motley Fool
Thermo Fisher (TMO) VP Holmes sells $189k in stock - Investing.com
Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site - citybiz
Thermo Fisher Scientific Acquires Solventum’s Purification and Filtration Business For $4 Billion - citybiz
Published on: 2025-09-02 13:48:47 - Newser
Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific - MarketScreener
Thermo Fisher Scientific Inc. completed the acquisition of Purification Business of Solventum Corporation for approximately $4 billion. - MarketScreener
Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business - PharmiWeb.com
Thermo Fisher Completes $4 Billion Solventum Acquisition - TipRanks
Thermo Fisher Scientific Acquires NJ Site from Sanofi - Contract Pharma
Solventum completes $4.1B sale of Purification & Filtration business to Thermo Fisher - MassDevice
Solventum Closes Sale of Purification, Filtration Business to Thermo Fisher - MarketScreener
Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield Facility in New Jersey - MarketScreener
Thermo Fisher’s Strategic Acquisition of Sanofi’s Ridgefield Site and Its Impact on Biopharma Manufacturing Growth - AInvest
Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. - MarketScreener
Is Thermo Fisher Scientific Inc. stock undervalued right nowGlobal Markets & Trade Opportunity Analysis - خودرو بانک
Thermo Fisher Scientific's Valuation: Assessing Growth Potential After New Facility and Nalgene Product Launches - Yahoo Finance
Can swing trading help recover from Thermo Fisher Scientific Inc. lossesWeekly Trade Report & Weekly Breakout Opportunity Watchlist - Newser
Volume spikes in Thermo Fisher Scientific Inc. stock – what they mean2025 Bull vs Bear & Verified Entry Point Signals - Newser
Is Thermo Fisher Scientific Inc. a play on infrastructure spendingJuly 2025 Rallies & Weekly High Momentum Picks - khodrobank.com
Can Thermo Fisher Scientific Inc. expand into new marketsMarket Activity Report & Fast Entry Momentum Alerts - khodrobank.com
Is Thermo Fisher Scientific Inc. impacted by rising rates2025 Support & Resistance & Risk Controlled Stock Pick Alerts - خودرو بانک
Thermo Fisher Expands US Base With New Mebane Facility - Healthcare Digital
Price Over Earnings Overview: Thermo Fisher Scientific - Benzinga
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):